Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
NewsSNMMI Newsline

JNM Impact Factor Rises Again

Journal of Nuclear Medicine August 2022, 63 (8) 18N;
  • Article
  • Info & Metrics
  • PDF
Loading

SNMMI and editors of The Journal of Nuclear Medicine (JNM) announced on June 28 that the publication had achieved the highest impact factor in its history, ranking fourth among all medical imaging journals, according to new data released in the 2021 Journal Citation Reports. “This continued rise in visibility emphasizes not only the high quality of the journal but also the rise in importance of nuclear medicine as a whole,” said JNM editor-in-chief Johannes Czernin, MD. “Revolutionary advances in nuclear medicine research are resulting in revolutionary care for patients.”

JNM’s impact factor increased more than 10% over last year, from 10.057 (2020) to 11.082 (2021). With 35,215 total citations, the journal was fourth in impact factor and third in Journal Citation Indicator among 200 journals in the medical imaging category. JNM’s total citations increased by 7%, and its 5-year impact factor increased almost 15%. Among nuclear medicine journals, JNM continues to have the highest impact factor, total citations, 5-year impact factor, Eigenfactor and normalized Eigenfactor scores, and article influence score.

“This is a tribute to the contributions of diverse scientists from all areas of the field, from advances in imaging instrumentation to important aspects of theranostic and therapeutic approaches,” said Czernin. JNM has highlighted some of those advances in recent supplements focused on personalized dosimetry for cancer therapy, nuclear endocrinology, and molecular imaging of neurodegeneration.

The impact factor is a quantitative measure of the frequency with which an article in a journal is cited. It is used as a measure of the overall influence of a journal within scientific, professional, and academic communities. “I am grateful for the support of SNMMI and its Publications Committee, the valuable contributions of our staff, the vital input from our editorial board and reviewers, and the dedication and expertise of the team of associate editors whose work made this success possible,” said Czernin.

SNMMI

  • © 2022 by the Society of Nuclear Medicine and Molecular Imaging.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (8)
Journal of Nuclear Medicine
Vol. 63, Issue 8
August 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
JNM Impact Factor Rises Again
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
JNM Impact Factor Rises Again
Journal of Nuclear Medicine Aug 2022, 63 (8) 18N;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
JNM Impact Factor Rises Again
Journal of Nuclear Medicine Aug 2022, 63 (8) 18N;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • NewsBriefs
  • SNMMI Adopts New Strategic Plan
  • 2022 SNMMI Highlights Lecture: Oncology and Therapy, Part 1
Show more SNMMI Newsline

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire